A similar elevation of FVIII was observed in both COVID-19 (+) (Median:1.769 and IQR:1.031–3.366 U/mL) and COVID-19 (−) (Median:1.79 and IQR:0.898–3.283 U/mL) patients (Figure 1C, FVIII reference range: ~0.5–1.5 U/mL) with no significant differences between the groups. Here, F8 is linked to COVID-19.